Literature DB >> 61035

Letter: Serum beta2-microglobulin and SLE.

M Weissel, O Scherak, H Fritzsche, G Kolarz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 61035     DOI： 10.1002/art.1780190532

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  7 in total

Review 1.  Dialysis arthropathy, amyloidosis and beta-2 microglobulin.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

2.  Beta 2-microglobulin and its binding activity in serum from patients with SLE.

Authors:  P E Evrin; T Ström
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

3.  Prevalence of anti-beta-2 microglobulin autoantibodies in sera of rheumatoid arthritis patients with extra-articular manifestations.

Authors:  A Falus; K Merétey; S Bozsóky
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

4.  Plasma levels of beta 2-microglobulin in rheumatoid arthritis.

Authors:  K G Sjöblom; T Saxne; F A Wollheim
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

5.  Serum beta 2-microglobulin, sialic acid, and C-reactive protein in systemic lupus erythematosus.

Authors:  C P Maury; T Helve; C Sjöblom
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

6.  Treatment of solid tumors should obligatorily be combined with the in vivo codepletion of tumor-protecting, CD8+/HLA-DR(+)-suppressor T cells by alloreactive donor T cells whose preprogrammed cell death allows a high GvL-effect before GvHD can be established. Results of animal experiments, including more than 6000 mice.

Authors:  P Leskovar; J Bielmeier
Journal:  Pflugers Arch       Date:  1996       Impact factor: 3.657

7.  Autoantibodies in Spondyloarthritis, Focusing on Anti-CD74 Antibodies.

Authors:  Yuan Liu; Xining Liao; Guixiu Shi
Journal:  Front Immunol       Date:  2019-01-22       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.